Allarity Therapeutics, Inc.

8-K Shareholder vote results; Other events Jul 1, 2026 8-K Other events Jun 22, 2026 8-K Director or officer change Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure; Other events May 8, 2026 8-K Other events May 6, 2026 8-K Other events Apr 28, 2026 8-K Other events Apr 22, 2026 8-K Results of operations (earnings release) Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Other events Mar 9, 2026 8-K Entered a material agreement; Took on a direct financial obligation Mar 6, 2026 8-K Other events Feb 19, 2026 8-K Other events Feb 4, 2026 8-K Entered a material agreement Jan 29, 2026 8-K Unregistered sale of equity Dec 23, 2025 8-K Director or officer change Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Other events Sep 24, 2025 8-K Entered a material agreement; Unregistered sale of equity Sep 22, 2025 8-K Other events Sep 22, 2025 8-K Other events Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 15, 2025 8-K Other events Jul 16, 2025 8-K Director or officer change Jul 7, 2025 8-K Other events Jul 1, 2025 8-K Other events Jun 30, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Director or officer change Jun 11, 2025 8-K Other events Jun 5, 2025 8-K Other events Jun 3, 2025 8-K Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 8-K Other events Apr 28, 2025 8-K Director or officer change; Item 5.08 Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Other events Mar 25, 2025 8-K Other events Mar 18, 2025